Charles A. Nicolette

Charles Nicolette joined Argos Therapeutics in 2003. Dr. Nicolette has extensive experience in the field of cancer immunotherapy and is the inventor on dozens of patent applications and issued patents relating to the development of personalized immunotherapeutics for cancer and infectious diseases. He was formerly the Director of Antigen Discovery at Genzyme Molecular Oncology where he developed SPHERE technology, the subject of one of the largest biotechnology deals ever done in the field of tumor antigen discovery. He is an expert in cellular immunology and brings substantial immunological sophistication to Argos. Dr. Nicolette received his Ph.D. in biochemistry and cellular and developmental biology from the State University of New York at Stony Brook, completing his doctoral dissertation and post-doctoral fellowship at Cold Spring Harbor Laboratory.